- Home
- THC vs TECH Comparison
THC vs TECH Comparison
Compare THC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THC
- TECH
- Stock Information
- Founded
- THC 1967
- TECH 1976
- Country
- THC United States
- TECH United States
- Employees
- THC N/A
- TECH N/A
- Industry
- THC Hospital/Nursing Management
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- THC Health Care
- TECH Health Care
- Exchange
- THC Nasdaq
- TECH Nasdaq
- Market Cap
- THC 13.2B
- TECH 12.0B
- IPO Year
- THC N/A
- TECH 1989
- Fundamental
- Price
- THC $129.70
- TECH $64.92
- Analyst Decision
- THC Buy
- TECH Buy
- Analyst Count
- THC 18
- TECH 7
- Target Price
- THC $163.94
- TECH $84.29
- AVG Volume (30 Days)
- THC 1.5M
- TECH 1.6M
- Earning Date
- THC 02-12-2025
- TECH 02-05-2025
- Dividend Yield
- THC N/A
- TECH 0.49%
- EPS Growth
- THC 473.07
- TECH N/A
- EPS
- THC 32.70
- TECH 0.98
- Revenue
- THC $20,665,000,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- THC $3.99
- TECH $7.50
- Revenue Next Year
- THC $4.87
- TECH $9.15
- P/E Ratio
- THC $3.99
- TECH $66.36
- Revenue Growth
- THC 0.57
- TECH 4.46
- 52 Week Low
- THC $88.98
- TECH $61.16
- 52 Week High
- THC $171.20
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- THC 41.92
- TECH 29.97
- Support Level
- THC $131.74
- TECH $63.51
- Resistance Level
- THC $138.11
- TECH $67.19
- Average True Range (ATR)
- THC 6.67
- TECH 2.76
- MACD
- THC -0.88
- TECH -0.71
- Stochastic Oscillator
- THC 24.13
- TECH 8.94
About THC Tenet Healthcare Corporation
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.